Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Secondary agoraphobia: two case reports.

J Z Sadler, A J Rush, T Caldwell

    The Journal of Clinical Psychiatry
    |November 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Major depressive disorder and agoraphobia may improve with antidepressant treatment. Dexamethasone suppression test (DST) normalization occurred with depression remission, suggesting agoraphobia was secondary to depression.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Resolutions of Delta County Medical Society.

    Daniel's Texas medical journal·2023
    Same author

    The 'difficult-to-treat depression' and the 'response paradigm' models: Implications and relevance to patient management.

    The Australian and New Zealand journal of psychiatry·2021
    Same author

    The identification, assessment and management of difficult-to-treat depression: An international consensus statement.

    Journal of affective disorders·2020
    Same author

    Treatment modalities and outcomes of pleomorphic hyalinizing angiectatic tumor: a systematic review of the literature.

    Musculoskeletal surgery·2018
    Same author

    Estimating surface soil moisture from SMAP observations using a Neural Network technique.

    Remote sensing of environment·2018
    Same author

    Increased hippocampal tail volume predicts depression status and remission to anti-depressant medications in major depression.

    Molecular psychiatry·2017
    Same journal

    Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

    The Journal of clinical psychiatry·2026
    Same journal

    Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

    The Journal of clinical psychiatry·2026
    Same journal

    Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

    The Journal of clinical psychiatry·2026
    Same journal

    Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

    The Journal of clinical psychiatry·2026
    Same journal

    Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

    The Journal of clinical psychiatry·2026
    Same journal

    The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

    The Journal of clinical psychiatry·2026
    See all related articles

    Area of Science:

    • Neuropsychiatry
    • Endocrinology
    • Pharmacology

    Background:

    • Agoraphobia and major depressive disorder (MDD) are common psychiatric conditions.
    • Dexamethasone nonsuppression (a marker of HPA axis dysregulation) is observed in some patients with MDD.
    • The relationship between agoraphobia, MDD, and HPA axis function requires further investigation.